These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6003713)

  • 1. [The effectiveness of vaccinating 3 to 7 year old children against typhoid fever with a purified preparation of S. typhi Vi-antigen (based on data from a controlled epidemiologic trial)].
    Shatrov II; Pokrovskaia MP; Braĭnina RA; Chernysheva NA; Spotarenko SS; Sraskina NA; Allakhverdov EM; Gavrilova AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):39-43. PubMed ID: 6003713
    [No Abstract]   [Full Text] [Related]  

  • 2. [The reactogenicity and immunologic effectiveness of a purified chemical preparation of S. typhi Vi-antigen in 3 to 7-year-old children].
    Chernysheva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):58-61. PubMed ID: 6005089
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
    Fraser A; Paul M; Goldberg E; Acosta CJ; Leibovici L
    Vaccine; 2007 Nov; 25(45):7848-57. PubMed ID: 17928109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for preventing typhoid fever.
    Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Jin C; Gibani MM; Moore M; Juel HB; Jones E; Meiring J; Harris V; Gardner J; Nebykova A; Kerridge SA; Hill J; Thomaides-Brears H; Blohmke CJ; Yu LM; Angus B; Pollard AJ
    Lancet; 2017 Dec; 390(10111):2472-2480. PubMed ID: 28965718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccines for preventing typhoid fever.
    Engels EA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001261. PubMed ID: 10796623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled field trials of three different oral killed typhoid vaccines in India.
    Chuttani CS
    Dev Biol Stand; 1976; 33():98-101. PubMed ID: 782977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2.
    Wahdan MH; Sippel JE; Mikhail IA; Rahka AE; Anderson ES; Sparks HA; Cvjetanović B
    Bull World Health Organ; 1975; 52(1):69-73. PubMed ID: 1082383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The experimental basis of various problems in enteral vaccination. 2. Effectiveness of Vi- and O-antigen typhoid vaccines when used enterally].
    Kovaleva NI; Mironova MV; Khatuntseva NV
    Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):9-13. PubMed ID: 5346282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental studies on various types of oral typhoid vaccines in animals and man].
    Saletti M; Panero C; Genna G; Riparbelli G; Morgese G
    Prog Immunobiol Stand; 1970; 4():372-9. PubMed ID: 5482183
    [No Abstract]   [Full Text] [Related]  

  • 14. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the immunologic indices of rabbits immunized with typhoid culture and alcohol monovaccine].
    Blant ME
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):48-52. PubMed ID: 6003716
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
    Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
    Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in vaccines for typhoid fever.
    Gupta A; Jalla S; Sazawal S; Bhan MK
    Indian J Pediatr; 1994; 61(4):321-39. PubMed ID: 8002060
    [No Abstract]   [Full Text] [Related]  

  • 18. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the possibility of vaccinating 3-7 year old children with S. typhi Vi-antigen in foci of typhoid fever].
    Chernysheva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jul; 44(7):140. PubMed ID: 5617045
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a Vi-degrading enzyme on potency of typhoid vaccines in mice.
    Wong KH; Feeley JC; Pittman M
    J Infect Dis; 1972 Apr; 125(4):360-6. PubMed ID: 4553079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.